19 results
8-K
EX-10.1
CRGX
CARGO Therapeutics Inc
28 May 24
Entry into a Material Definitive Agreement
8:14am
by the U.S. Food and Drug Administration (“FDA”) and other comparable governmental entities having oversight over the ownership, testing, development
DEF 14A
CRGX
CARGO Therapeutics Inc
24 Apr 24
Definitive proxy
4:27pm
of internal controls. In fulfilling its oversight responsibilities, the Audit Committee reviewed and discussed with management CARGO’s audited … by Auditing Standard 1301, Communications with Audit Committees, as adopted by the Public Company Accounting Oversight Board (the “PCAOB”). In addition
10-K
2023 FY
CRGX
CARGO Therapeutics Inc
21 Mar 24
Annual report
4:21pm
civil and criminal penalties, damages, disgorgement fines, additional reporting requirements and oversight obligations, contractual damages … regulatory oversight by the FDA in connection with our clinical trials, and in addition, the applicable IBC and Institutional Review Board (IRB) of each
10-Q
2023 Q3
CRGX
CARGO Therapeutics Inc
13 Dec 23
Quarterly report
4:31pm
that we are taking are subject to ongoing senior management review, as well as audit committee oversight. We will not be able to conclude whether
424B4
lrs0 bhp6l5atv
13 Nov 23
Prospectus supplement with pricing info
4:31pm
S-1
jdrh 3hn021qd0ha
20 Oct 23
IPO registration
4:07pm
S-1
EX-10.8
5bnb 4oztrd6n3s
20 Oct 23
IPO registration
4:07pm
S-1
EX-10.9
b9nbisvmgct7g
20 Oct 23
IPO registration
4:07pm
S-1
EX-10.14
e27 w4mfhtt5ojzwbac
20 Oct 23
IPO registration
4:07pm
S-1
EX-10.10
ajd4o3btmr88vkt5
20 Oct 23
IPO registration
4:07pm
DRS/A
8w7 qvkuun679l
4 Oct 23
Draft registration statement (amended)
12:00am
DRS
7qfjl9g3uanw0q
1 Sep 23
Draft registration statement
12:00am
- Prev
- 1
- Next